Caliway Biopharmaceuticals Co Ltd banner
C

Caliway Biopharmaceuticals Co Ltd
TWSE:6919

Watchlist Manager
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Watchlist
Price: 164 TWD 2.5%
Market Cap: NT$254.8B

Cash Flow Statement

Cash Flow Statement
Caliway Biopharmaceuticals Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: TWD
Dec-2022 Jun-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(286)
(429)
(488)
(706)
(622)
(760)
(589)
(546)
(618)
(488)
Depreciation & Amortization
25
27
28
35
28
36
30
30
31
31
Stock-Based Compensation
19
0
23
4
8
27
49
78
156
0
Other Non-Cash Items
15
14
6
6
(7)
16
(9)
(20)
28
(73)
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
1
1
0
1
0
1
0
0
0
0
Change in Working Capital
3
4
31
82
51
38
46
56
102
125
Cash from Operating Activities
(243)
N/A
(384)
-58%
(424)
-10%
(584)
-38%
(550)
+6%
(669)
-22%
(522)
+22%
(480)
+8%
(458)
+5%
(407)
+11%
Investing Cash Flow
Capital Expenditures
(14)
(10)
(10)
(11)
(16)
(19)
(11)
(14)
(10)
(13)
Other Items
(456)
(57)
167
167
(309)
(287)
(2 478)
35
(1 137)
(5 610)
Cash from Investing Activities
(471)
N/A
(67)
+86%
157
N/A
156
-1%
(326)
N/A
(307)
+6%
(2 489)
-712%
22
N/A
(1 147)
N/A
(5 624)
-390%
Financing Cash Flow
Net Issuance of Common Stock
784
9
3 042
3 043
3 043
9 521
6 499
6 504
6 538
40
Net Issuance of Debt
(13)
(8)
(8)
(10)
(8)
(11)
(9)
(9)
(9)
(9)
Cash from Financing Activities
772
N/A
1
-100%
3 034
+324 352%
3 033
0%
3 035
+0%
9 511
+213%
6 491
-32%
6 496
+0%
6 529
+1%
32
-100%
Change in Cash
Effect of Foreign Exchange Rates
2
0
0
0
1
1
(0)
0
(1)
(26)
Net Change in Cash
60
N/A
(451)
N/A
2 767
N/A
2 605
-6%
2 160
-17%
8 536
+295%
3 479
-59%
6 038
+74%
4 924
-18%
(6 025)
N/A
Free Cash Flow
Free Cash Flow
(257)
N/A
(395)
-54%
(434)
-10%
(595)
-37%
(566)
+5%
(688)
-22%
(533)
+22%
(494)
+7%
(468)
+5%
(420)
+10%